<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:0fa91957-3be9-46eb-b299-c64726ab29b8,g:54959551-51d6-4058-9de7-5561dedcaa94-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:vrdn="http://www.viridiantherapeutics.com/20251231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.viridiantherapeutics.com/20251231">
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/cyd-af-sub/2025" schemaLocation="https://xbrl.sec.gov/cyd/2025/cyd-af-sub-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vrdn-20251231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vrdn-20251231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vrdn-20251231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vrdn-20251231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.viridiantherapeutics.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.viridiantherapeutics.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.viridiantherapeutics.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>9952151 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.viridiantherapeutics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>9952152 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" roleURI="http://www.viridiantherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS">
        <link:definition>9952153 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.viridiantherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>9952154 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" roleURI="http://www.viridiantherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical">
        <link:definition>9952155 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.viridiantherapeutics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>9952156 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFTHEBUSINESS" roleURI="http://www.viridiantherapeutics.com/role/DESCRIPTIONOFTHEBUSINESS">
        <link:definition>9952157 - Disclosure - DESCRIPTION OF THE BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.viridiantherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>9952158 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTS" roleURI="http://www.viridiantherapeutics.com/role/MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTS">
        <link:definition>9952159 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENT" roleURI="http://www.viridiantherapeutics.com/role/PROPERTYANDEQUIPMENT">
        <link:definition>9952160 - Disclosure - PROPERTY AND EQUIPMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDLIABILITIES" roleURI="http://www.viridiantherapeutics.com/role/ACCRUEDLIABILITIES">
        <link:definition>9952161 - Disclosure - ACCRUED LIABILITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://www.viridiantherapeutics.com/role/DEBT">
        <link:definition>9952162 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PURCHASEANDSALEOFTHEREVENUEPARTICIPATIONRIGHT" roleURI="http://www.viridiantherapeutics.com/role/PURCHASEANDSALEOFTHEREVENUEPARTICIPATIONRIGHT">
        <link:definition>9952163 - Disclosure - PURCHASE AND SALE OF THE REVENUE PARTICIPATION RIGHT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COLLABORATIONANDLICENSEAGREEMENTS" roleURI="http://www.viridiantherapeutics.com/role/COLLABORATIONANDLICENSEAGREEMENTS">
        <link:definition>9952164 - Disclosure - COLLABORATION AND LICENSE AGREEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://www.viridiantherapeutics.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>9952165 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CAPITALSTOCK" roleURI="http://www.viridiantherapeutics.com/role/CAPITALSTOCK">
        <link:definition>9952166 - Disclosure - CAPITAL STOCK</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WARRANTS" roleURI="http://www.viridiantherapeutics.com/role/WARRANTS">
        <link:definition>9952167 - Disclosure - WARRANTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATION" roleURI="http://www.viridiantherapeutics.com/role/SHAREBASEDCOMPENSATION">
        <link:definition>9952168 - Disclosure - SHARE-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLAN" roleURI="http://www.viridiantherapeutics.com/role/RETIREMENTBENEFITPLAN">
        <link:definition>9952169 - Disclosure - RETIREMENT BENEFIT PLAN</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETLOSSPERSHARE" roleURI="http://www.viridiantherapeutics.com/role/NETLOSSPERSHARE">
        <link:definition>9952170 - Disclosure - NET LOSS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.viridiantherapeutics.com/role/INCOMETAXES">
        <link:definition>9952171 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATION" roleURI="http://www.viridiantherapeutics.com/role/SEGMENTINFORMATION">
        <link:definition>9952172 - Disclosure - SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.viridiantherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>9955511 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSTables" roleURI="http://www.viridiantherapeutics.com/role/MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSTables">
        <link:definition>9955512 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTTables" roleURI="http://www.viridiantherapeutics.com/role/PROPERTYANDEQUIPMENTTables">
        <link:definition>9955513 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDLIABILITIESTables" roleURI="http://www.viridiantherapeutics.com/role/ACCRUEDLIABILITIESTables">
        <link:definition>9955514 - Disclosure - ACCRUED LIABILITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTTables" roleURI="http://www.viridiantherapeutics.com/role/DEBTTables">
        <link:definition>9955515 - Disclosure - DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PURCHASEANDSALEOFTHEREVENUEPARTICIPATIONRIGHTTables" roleURI="http://www.viridiantherapeutics.com/role/PURCHASEANDSALEOFTHEREVENUEPARTICIPATIONRIGHTTables">
        <link:definition>9955516 - Disclosure - PURCHASE AND SALE OF THE REVENUE PARTICIPATION RIGHT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESTables" roleURI="http://www.viridiantherapeutics.com/role/COMMITMENTSANDCONTINGENCIESTables">
        <link:definition>9955517 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WARRANTSTables" roleURI="http://www.viridiantherapeutics.com/role/WARRANTSTables">
        <link:definition>9955518 - Disclosure - WARRANTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONTables" roleURI="http://www.viridiantherapeutics.com/role/SHAREBASEDCOMPENSATIONTables">
        <link:definition>9955519 - Disclosure - SHARE-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETLOSSPERSHARETables" roleURI="http://www.viridiantherapeutics.com/role/NETLOSSPERSHARETables">
        <link:definition>9955520 - Disclosure - NET LOSS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTables" roleURI="http://www.viridiantherapeutics.com/role/INCOMETAXESTables">
        <link:definition>9955521 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONTables" roleURI="http://www.viridiantherapeutics.com/role/SEGMENTINFORMATIONTables">
        <link:definition>9955522 - Disclosure - SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFTHEBUSINESSDetails" roleURI="http://www.viridiantherapeutics.com/role/DESCRIPTIONOFTHEBUSINESSDetails">
        <link:definition>9955523 - Disclosure - DESCRIPTION OF THE BUSINESS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" roleURI="http://www.viridiantherapeutics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails">
        <link:definition>9955524 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSScheduleofDebtSecuritiesAvailableforsaleDetails" roleURI="http://www.viridiantherapeutics.com/role/MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSScheduleofDebtSecuritiesAvailableforsaleDetails">
        <link:definition>9955525 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS - Schedule of Debt Securities, Available-for-sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSNarrativeDetails" roleURI="http://www.viridiantherapeutics.com/role/MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSNarrativeDetails">
        <link:definition>9955526 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" roleURI="http://www.viridiantherapeutics.com/role/MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails">
        <link:definition>9955527 - Disclosure - MARKETABLE SECURITIES AND FAIR VALUE MEASUREMENTS - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTScheduleofComponentsofPropertyandEquipmentDetails" roleURI="http://www.viridiantherapeutics.com/role/PROPERTYANDEQUIPMENTScheduleofComponentsofPropertyandEquipmentDetails">
        <link:definition>9955528 - Disclosure - PROPERTY AND EQUIPMENT - Schedule of Components of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTNarrativeDetails" roleURI="http://www.viridiantherapeutics.com/role/PROPERTYANDEQUIPMENTNarrativeDetails">
        <link:definition>9955529 - Disclosure - PROPERTY AND EQUIPMENT - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDLIABILITIESDetails" roleURI="http://www.viridiantherapeutics.com/role/ACCRUEDLIABILITIESDetails">
        <link:definition>9955530 - Disclosure - ACCRUED LIABILITIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTNarrativeDetails" roleURI="http://www.viridiantherapeutics.com/role/DEBTNarrativeDetails">
        <link:definition>9955531 - Disclosure - DEBT - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTScheduleofComponentsofTheAmendedTermLoanDetails" roleURI="http://www.viridiantherapeutics.com/role/DEBTScheduleofComponentsofTheAmendedTermLoanDetails">
        <link:definition>9955532 - Disclosure - DEBT - Schedule of Components of The Amended Term Loan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTScheduleofFuturePrincipalPaymentsofDebtDetails" roleURI="http://www.viridiantherapeutics.com/role/DEBTScheduleofFuturePrincipalPaymentsofDebtDetails">
        <link:definition>9955533 - Disclosure - DEBT - Schedule of Future Principal Payments of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PURCHASEANDSALEOFTHEREVENUEPARTICIPATIONRIGHTNarrativeDetails" roleURI="http://www.viridiantherapeutics.com/role/PURCHASEANDSALEOFTHEREVENUEPARTICIPATIONRIGHTNarrativeDetails">
        <link:definition>9955534 - Disclosure - PURCHASE AND SALE OF THE REVENUE PARTICIPATION RIGHT - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PURCHASEANDSALEOFTHEREVENUEPARTICIPATIONRIGHTActivityOfLiabilityDetails" roleURI="http://www.viridiantherapeutics.com/role/PURCHASEANDSALEOFTHEREVENUEPARTICIPATIONRIGHTActivityOfLiabilityDetails">
        <link:definition>9955535 - Disclosure - PURCHASE AND SALE OF THE REVENUE PARTICIPATION RIGHT - Activity Of Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PURCHASEANDSALEOFTHEREVENUEPARTICIPATIONRIGHTActivityOfDerivativeLiabilityDetails" roleURI="http://www.viridiantherapeutics.com/role/PURCHASEANDSALEOFTHEREVENUEPARTICIPATIONRIGHTActivityOfDerivativeLiabilityDetails">
        <link:definition>9955536 - Disclosure - PURCHASE AND SALE OF THE REVENUE PARTICIPATION RIGHT - Activity Of Derivative Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COLLABORATIONANDLICENSEAGREEMENTSDetails" roleURI="http://www.viridiantherapeutics.com/role/COLLABORATIONANDLICENSEAGREEMENTSDetails">
        <link:definition>9955537 - Disclosure - COLLABORATION AND LICENSE AGREEMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESNarrativeDetails" roleURI="http://www.viridiantherapeutics.com/role/COMMITMENTSANDCONTINGENCIESNarrativeDetails">
        <link:definition>9955538 - Disclosure - COMMITMENTS AND CONTINGENCIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESScheduleofFutureLeasePaymentsunderNoncancelableLeasesDetails" roleURI="http://www.viridiantherapeutics.com/role/COMMITMENTSANDCONTINGENCIESScheduleofFutureLeasePaymentsunderNoncancelableLeasesDetails">
        <link:definition>9955539 - Disclosure - COMMITMENTS AND CONTINGENCIES - Schedule of Future Lease Payments under Noncancelable Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESScheduleofFutureLeasePaymentsunderNoncancelableLeasesDetails_1" roleURI="http://www.viridiantherapeutics.com/role/COMMITMENTSANDCONTINGENCIESScheduleofFutureLeasePaymentsunderNoncancelableLeasesDetails_1">
        <link:definition>9955539 - Disclosure - COMMITMENTS AND CONTINGENCIES - Schedule of Future Lease Payments under Noncancelable Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CAPITALSTOCKDetails" roleURI="http://www.viridiantherapeutics.com/role/CAPITALSTOCKDetails">
        <link:definition>9955540 - Disclosure - CAPITAL STOCK (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WARRANTSScheduleofStockWarrantsOutstandingDetails" roleURI="http://www.viridiantherapeutics.com/role/WARRANTSScheduleofStockWarrantsOutstandingDetails">
        <link:definition>9955541 - Disclosure - WARRANTS - Schedule of Stock Warrants Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WARRANTSScheduleofStockWarrantActivityDetails" roleURI="http://www.viridiantherapeutics.com/role/WARRANTSScheduleofStockWarrantActivityDetails">
        <link:definition>9955542 - Disclosure - WARRANTS - Schedule of Stock Warrant Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONNarrativeDetails" roleURI="http://www.viridiantherapeutics.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails">
        <link:definition>9955543 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONScheduleofBalancesbyPlanDetails" roleURI="http://www.viridiantherapeutics.com/role/SHAREBASEDCOMPENSATIONScheduleofBalancesbyPlanDetails">
        <link:definition>9955544 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Balances by Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONScheduleofRestrictedStockUnitsDetails" roleURI="http://www.viridiantherapeutics.com/role/SHAREBASEDCOMPENSATIONScheduleofRestrictedStockUnitsDetails">
        <link:definition>9955545 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Restricted Stock Units (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONStockOptionActivityDetails" roleURI="http://www.viridiantherapeutics.com/role/SHAREBASEDCOMPENSATIONStockOptionActivityDetails">
        <link:definition>9955546 - Disclosure - SHARE-BASED COMPENSATION - Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONScheduleofFairValueAssumptionsforStockOptionsDetails" roleURI="http://www.viridiantherapeutics.com/role/SHAREBASEDCOMPENSATIONScheduleofFairValueAssumptionsforStockOptionsDetails">
        <link:definition>9955547 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Fair Value Assumptions for Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONScheduleofAllocationofSharebasedCompensationExpenseDetails" roleURI="http://www.viridiantherapeutics.com/role/SHAREBASEDCOMPENSATIONScheduleofAllocationofSharebasedCompensationExpenseDetails">
        <link:definition>9955548 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Allocation of Share-based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RETIREMENTBENEFITPLANDetails" roleURI="http://www.viridiantherapeutics.com/role/RETIREMENTBENEFITPLANDetails">
        <link:definition>9955549 - Disclosure - RETIREMENT BENEFIT PLAN (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETLOSSPERSHAREScheduleofBasicAndDilutedNetLossPerShareDetails" roleURI="http://www.viridiantherapeutics.com/role/NETLOSSPERSHAREScheduleofBasicAndDilutedNetLossPerShareDetails">
        <link:definition>9955550 - Disclosure - NET LOSS PER SHARE - Schedule of Basic And Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETLOSSPERSHAREScheduleofPotentiallyDilutiveSecuritiesDetails" roleURI="http://www.viridiantherapeutics.com/role/NETLOSSPERSHAREScheduleofPotentiallyDilutiveSecuritiesDetails">
        <link:definition>9955551 - Disclosure - NET LOSS PER SHARE - Schedule of Potentially Dilutive Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails" roleURI="http://www.viridiantherapeutics.com/role/INCOMETAXESScheduleofEffectiveTaxRateReconciliationDetails">
        <link:definition>9955552 - Disclosure - INCOME TAXES - Schedule of Effective Tax Rate Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.viridiantherapeutics.com/role/INCOMETAXESScheduleofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>9955553 - Disclosure - INCOME TAXES - Schedule of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESNarrativeDetails" roleURI="http://www.viridiantherapeutics.com/role/INCOMETAXESNarrativeDetails">
        <link:definition>9955554 - Disclosure - INCOME TAXES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONNarrativeDetails" roleURI="http://www.viridiantherapeutics.com/role/SEGMENTINFORMATIONNarrativeDetails">
        <link:definition>9955555 - Disclosure - SEGMENT INFORMATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONScheduleofSegmentReportingInformationbySegmentDetails" roleURI="http://www.viridiantherapeutics.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationbySegmentDetails">
        <link:definition>9955556 - Disclosure - SEGMENT INFORMATION - Schedule of Segment Reporting Information, by Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="vrdn_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vrdn_CollaborationMember" abstract="true" name="CollaborationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_AtTheMarketOfferingMember" abstract="true" name="AtTheMarketOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_January2024UnderwrittenOfferingMember" abstract="true" name="January2024UnderwrittenOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_September2024UnderwrittenOfferingMember" abstract="true" name="September2024UnderwrittenOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_StockIssuedDuringPeriodValueWarrantsExercisedShares" abstract="false" name="StockIssuedDuringPeriodValueWarrantsExercisedShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="vrdn_StockIssuedDuringPeriodValueWarrantsExercisedValue" abstract="false" name="StockIssuedDuringPeriodValueWarrantsExercisedValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_DerivativeLiabilityIssuanceCosts" abstract="false" name="DerivativeLiabilityIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_PaymentOfIssuanceCostsSaleOfFutureRevenue" abstract="false" name="PaymentOfIssuanceCostsSaleOfFutureRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_RemeasurementOfOperatingLeaseRightOfUseAssetsForLeaseModifications" abstract="false" name="RemeasurementOfOperatingLeaseRightOfUseAssetsForLeaseModifications" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_PurchaseAndSaleOfRevenueParticipationRightTextBlock" abstract="false" name="PurchaseAndSaleOfRevenueParticipationRightTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="vrdn_GoingConcernPolicyPolicyTextBlock" abstract="false" name="GoingConcernPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="vrdn_ClinicalTrialsAndNonclinicalStudyAccrualsPolicyTextBlock" abstract="false" name="ClinicalTrialsAndNonclinicalStudyAccrualsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="vrdn_WarrantsPolicyPolicyTextBlock" abstract="false" name="WarrantsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="vrdn_AccruedOutsourcedManufacturingCurrent" abstract="false" name="AccruedOutsourcedManufacturingCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_AccruedMilestonePaymentCurrent" abstract="false" name="AccruedMilestonePaymentCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_AccruedOutsourcedClinicalAndNonclinicalStudiesCurrent" abstract="false" name="AccruedOutsourcedClinicalAndNonclinicalStudiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_HerculesTermLoanMember" abstract="true" name="HerculesTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_DebtCovenantPeriodAxis" abstract="true" name="DebtCovenantPeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="vrdn_DebtCovenantPeriodDomain" abstract="true" name="DebtCovenantPeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_DebtCovenantPeriodOneMember" abstract="true" name="DebtCovenantPeriodOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_DebtCovenantPeriodTwoMember" abstract="true" name="DebtCovenantPeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_DebtInstrumentNumberOfTranches" abstract="false" name="DebtInstrumentNumberOfTranches" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vrdn_DebtInstrumentFaceAmountFirstTranche" abstract="false" name="DebtInstrumentFaceAmountFirstTranche" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_DebtInstrumentFaceAmountFourthTranche" abstract="false" name="DebtInstrumentFaceAmountFourthTranche" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_DebtInstrumentFaceAmountSecondTranche" abstract="false" name="DebtInstrumentFaceAmountSecondTranche" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_DebtInstrumentFaceAmountThirdTranche" abstract="false" name="DebtInstrumentFaceAmountThirdTranche" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_DebtInstrumentFaceAmountFifthTranche" abstract="false" name="DebtInstrumentFaceAmountFifthTranche" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_DebtInstrumentInterestRateMaximum" abstract="false" name="DebtInstrumentInterestRateMaximum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vrdn_DebtInstrumentPrincipalAmountTermFee" abstract="false" name="DebtInstrumentPrincipalAmountTermFee" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vrdn_DebtInstrumentPrincipalAmountTermFeeAtMaturity" abstract="false" name="DebtInstrumentPrincipalAmountTermFeeAtMaturity" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vrdn_AccruedDebtFees" abstract="false" name="AccruedDebtFees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_SaleOfFutureRevenueMember" abstract="true" name="SaleOfFutureRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_SaleOfFutureRevenueMilestoneAndMarketingApprovalMember" abstract="true" name="SaleOfFutureRevenueMilestoneAndMarketingApprovalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_SaleOfFutureRevenueMilestoneMember" abstract="true" name="SaleOfFutureRevenueMilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_SaleOfFutureRevenueMarketingApprovalMember" abstract="true" name="SaleOfFutureRevenueMarketingApprovalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_SaleOfFutureRevenueNetSalesAchievementMember" abstract="true" name="SaleOfFutureRevenueNetSalesAchievementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_SaleOfFutureRevenueAgreedUponFinancialTermsMember" abstract="true" name="SaleOfFutureRevenueAgreedUponFinancialTermsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_SaleOfFutureRevenueRoyaltyPaymentsTier1Member" abstract="true" name="SaleOfFutureRevenueRoyaltyPaymentsTier1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_SaleOfFutureRevenueRoyaltyPaymentsTier2Member" abstract="true" name="SaleOfFutureRevenueRoyaltyPaymentsTier2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_SaleOfFutureRevenueRoyaltyPaymentsTier3Member" abstract="true" name="SaleOfFutureRevenueRoyaltyPaymentsTier3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_SaleOfFutureRevenueRoyaltyPaymentsTier4Member" abstract="true" name="SaleOfFutureRevenueRoyaltyPaymentsTier4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_VeligrotugMember" abstract="true" name="VeligrotugMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_ElegrobartMember" abstract="true" name="ElegrobartMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_DebtInstrumentConditionalPayments" abstract="false" name="DebtInstrumentConditionalPayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_DebtInstrumentConditionalPaymentsSalesAchievementThreshold" abstract="false" name="DebtInstrumentConditionalPaymentsSalesAchievementThreshold" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_DebtInstrumentRoyaltyPaymentsPercentage" abstract="false" name="DebtInstrumentRoyaltyPaymentsPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vrdn_DebtInstrumentRoyaltyPaymentsThreshold" abstract="false" name="DebtInstrumentRoyaltyPaymentsThreshold" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_DebtAndDerivativeLiabilityIssuanceCosts" abstract="false" name="DebtAndDerivativeLiabilityIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_DerivativeLiabilityRollForward" abstract="true" name="DerivativeLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vrdn_ZenasBioPharmaMember" abstract="true" name="ZenasBioPharmaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_ParagonTherapeuticsMember" abstract="true" name="ParagonTherapeuticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_KisseiPharmaceuticalCo.LtdMember" abstract="true" name="KisseiPharmaceuticalCo.LtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_FairmountFundsManagementMember" abstract="true" name="FairmountFundsManagementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_ImmunoGenIncMember" abstract="true" name="ImmunoGenIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_EnableInjectionsMember" abstract="true" name="EnableInjectionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_ThirdPartyCollaboratorMember" abstract="true" name="ThirdPartyCollaboratorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_CollaborationArrangementFutureDevelopmentsMilestonePaymentObligation" abstract="false" name="CollaborationArrangementFutureDevelopmentsMilestonePaymentObligation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_CollaborationArrangementMaximumMilestonePayments" abstract="false" name="CollaborationArrangementMaximumMilestonePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_CollaborationArrangementMilestonePaymentIntellectualPropertyRightsDevelopmentMaximum" abstract="false" name="CollaborationArrangementMilestonePaymentIntellectualPropertyRightsDevelopmentMaximum" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_CollaborationArrangementCommercialMilestonePaymentIntellectualPropertyRightsDevelopmentMaximum" abstract="false" name="CollaborationArrangementCommercialMilestonePaymentIntellectualPropertyRightsDevelopmentMaximum" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_CollaborativeArrangementUpfrontFeePayment" abstract="false" name="CollaborativeArrangementUpfrontFeePayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_CollaborativeArrangementRightsAndObligationsMilestonePayment" abstract="false" name="CollaborativeArrangementRightsAndObligationsMilestonePayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_CollaborativeArrangementNumberOfPerformanceObligations" abstract="false" name="CollaborativeArrangementNumberOfPerformanceObligations" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vrdn_CollaborationArrangementPotentialMilestonePaymentMaximum" abstract="false" name="CollaborationArrangementPotentialMilestonePaymentMaximum" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_CollaborativeArrangementPotentialRoyaltyPaymentsMaximum" abstract="false" name="CollaborativeArrangementPotentialRoyaltyPaymentsMaximum" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_CollaborativeArrangementRightsAndLicensesFee" abstract="false" name="CollaborativeArrangementRightsAndLicensesFee" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_CollaborativeArrangementSharesIssuedForRightsGranted" abstract="false" name="CollaborativeArrangementSharesIssuedForRightsGranted" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="vrdn_CollaborativeArrangementValueOfSharesIssuedForRightsGranted" abstract="false" name="CollaborativeArrangementValueOfSharesIssuedForRightsGranted" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_CommitmentsandContingenciesTable" abstract="true" name="CommitmentsandContingenciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="vrdn_MassachusettsLeaseMember" abstract="true" name="MassachusettsLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_ColoradoLeaseMember" abstract="true" name="ColoradoLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_CommitmentsAndContingenciesLineItems" abstract="true" name="CommitmentsAndContingenciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vrdn_OperatingLeaseRightOfUseAssetDerecognized" abstract="false" name="OperatingLeaseRightOfUseAssetDerecognized" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_OperatingLeaseLiabilityCurrentDerecognized" abstract="false" name="OperatingLeaseLiabilityCurrentDerecognized" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_OperatingLeaseAnnualBaseRent" abstract="false" name="OperatingLeaseAnnualBaseRent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_OperatingLeasesOperatingExpense" abstract="false" name="OperatingLeasesOperatingExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_September2022ATMAgreementMember" abstract="true" name="September2022ATMAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_March2025ATMAgreementMember" abstract="true" name="March2025ATMAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_A2024PublicOfferingMember" abstract="true" name="A2024PublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_A2025PublicOfferingMember" abstract="true" name="A2025PublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_ViridianMergerMember" abstract="true" name="ViridianMergerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_CommonStockVoteperShare" abstract="false" name="CommonStockVoteperShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="vrdn_SaleofStockCommissionFeePercentageofGrossSaleProceeds" abstract="false" name="SaleofStockCommissionFeePercentageofGrossSaleProceeds" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vrdn_SaleOfStockWeightedAverageSharePrice" abstract="false" name="SaleOfStockWeightedAverageSharePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="vrdn_ClassOfWarrantOrRightConversionPercentageOfOwnership" abstract="false" name="ClassOfWarrantOrRightConversionPercentageOfOwnership" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vrdn_LiabilityClassifiedWarrantsIssuedApril2017Member" abstract="true" name="LiabilityClassifiedWarrantsIssuedApril2017Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_EquityclassifiedWarrantsMember" abstract="true" name="EquityclassifiedWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_EquityClassifiedWarrantsAcquiredOctober2020Member" abstract="true" name="EquityClassifiedWarrantsAcquiredOctober2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_EquityclassifiedWarrantsIssuedFebruary2020Member" abstract="true" name="EquityclassifiedWarrantsIssuedFebruary2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsNet" abstract="false" name="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsNet" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="vrdn_ClassofWarrantorRightRemainingTerm" abstract="false" name="ClassofWarrantorRightRemainingTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="vrdn_ClassofWarrantorRightActivityRollForward" abstract="true" name="ClassofWarrantorRightActivityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vrdn_ClassOfWarrantOrRightExercisedInPeriod" abstract="false" name="ClassOfWarrantOrRightExercisedInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="vrdn_ClassOfWarrantOrRightExpiredInPeriod" abstract="false" name="ClassOfWarrantOrRightExpiredInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="vrdn_ClassOfWarrantOrRightCashlessExercises" abstract="false" name="ClassOfWarrantOrRightCashlessExercises" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="vrdn_ClassofWarrantorRightWeightedAverageExercisePriceRollForward" abstract="true" name="ClassofWarrantorRightWeightedAverageExercisePriceRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="vrdn_ClassOfWarrantOrRightExercisedInPeriodWeightedAverageGrantDateFairValue" abstract="false" name="ClassOfWarrantOrRightExercisedInPeriodWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="vrdn_ClassOfWarrantOrRightExpiredInPeriodWeightedAverageGrantDateFairValue" abstract="false" name="ClassOfWarrantOrRightExpiredInPeriodWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="vrdn_A2016EmployeeStockPurchasePlanMember" abstract="true" name="A2016EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_A2025EmployeeStockPurchasePlanMember" abstract="true" name="A2025EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_FormerExecutiveOfficersMember" abstract="true" name="FormerExecutiveOfficersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_InducementGrantsMember" abstract="true" name="InducementGrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_A2020PlanMember" abstract="true" name="A2020PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_NetIncomeLossAttributableToParentAllocation" abstract="false" name="NetIncomeLossAttributableToParentAllocation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_CommonStockWarrantsMember" abstract="true" name="CommonStockWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_DeferredTaxAssetsTaxDeferredExpenseStartUpCostsAndAmortizedCosts" abstract="false" name="DeferredTaxAssetsTaxDeferredExpenseStartUpCostsAndAmortizedCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_DeferredTaxAssetsSaleOfFutureRevenues" abstract="false" name="DeferredTaxAssetsSaleOfFutureRevenues" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_DeferredTaxAssetsOperatingLeaseRightOfUseAssetNet" abstract="false" name="DeferredTaxAssetsOperatingLeaseRightOfUseAssetNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_OperatingLossCarryforwardsSubjectToExpiration" abstract="false" name="OperatingLossCarryforwardsSubjectToExpiration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_OperatingLossCarryforwardsLimitationsOnUsePercent" abstract="false" name="OperatingLossCarryforwardsLimitationsOnUsePercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vrdn_TaxCreditCarryforwardLimitationsOnUseAmount" abstract="false" name="TaxCreditCarryforwardLimitationsOnUseAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_TaxCreditCarryforwardWriteOff" abstract="false" name="TaxCreditCarryforwardWriteOff" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_DeferredTaxAssetsNetBeforeValuationAllowance" abstract="false" name="DeferredTaxAssetsNetBeforeValuationAllowance" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_DeferredTaxAssetValuationAllowancePercent" abstract="false" name="DeferredTaxAssetValuationAllowancePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="vrdn_ReportableSegmentMember" abstract="true" name="ReportableSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_ResearchAndDevelopmentExpenseExcludingShareBasedCompensationExpense" abstract="false" name="ResearchAndDevelopmentExpenseExcludingShareBasedCompensationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_SellingGeneralAndAdministrativeExpenseExcludingShareBasedCompensationExpense" abstract="false" name="SellingGeneralAndAdministrativeExpenseExcludingShareBasedCompensationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="vrdn_ThomasBeethamMember" abstract="true" name="ThomasBeethamMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_StephenMahoneyMember" abstract="true" name="StephenMahoneyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="vrdn_SethHarmonMember" abstract="true" name="SethHarmonMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
